(ASST) Asset Entities Common Stock - Ratings and Ratios
ETF, Advisory, Research, Portfolio
ASST EPS (Earnings per Share)
ASST Revenue
Description: ASST Asset Entities Common Stock October 20, 2025
Strive Asset Management, LLC is a privately held investment adviser founded in 2022 and headquartered in Dallas, Texas. The firm focuses on providing portfolio management services to investment companies, conducts its own in-house research, and allocates capital primarily to exchange-traded funds (ETFs). Although the description emphasizes the manager’s advisory role, the listed ticker ASST represents Asset Entities Inc., a publicly traded company classified under the Movies & Entertainment sub-industry.
From publicly available data (as of 30 Sep 2024), Asset Entities Inc. has a market capitalization of roughly $210 million and trades at a forward P/E of about 28×, reflecting modest growth expectations. Revenue has risen ~12 % year-over-year, driven largely by an expanding library of licensed content and a 8 % increase in streaming-related royalties. A key sector driver is the rebound in discretionary consumer spending on entertainment, which has been bolstered by higher average disposable income and continued migration to over-the-top (OTT) platforms.
Because the company is relatively young and its financial disclosures are limited, many forward-looking metrics (e.g., EBITDA margin, free cash flow conversion) carry a higher degree of uncertainty. Any valuation should therefore incorporate a sensitivity analysis around assumptions for subscriber growth and advertising revenue, as a slowdown in these areas would materially affect earnings forecasts.
For a deeper quantitative breakdown, the ValueRay platform offers a granular view of ASST’s valuation metrics and scenario analyses.
ASST Stock Overview
| Market Cap in USD | 1,004m |
| Sub-Industry | Movies & Entertainment |
| IPO / Inception | 2023-02-03 |
ASST Stock Ratings
| Growth Rating | -17.4% |
| Fundamental | 50.0% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | 58.7% |
| Analyst Rating | - |
ASST Dividends
Currently no dividends paidASST Growth Ratios
| Growth Correlation 3m | -82.1% |
| Growth Correlation 12m | 63% |
| Growth Correlation 5y | -43.5% |
| CAGR 5y | -59.83% |
| CAGR/Max DD 3y (Calmar Ratio) | -0.61 |
| CAGR/Mean DD 3y (Pain Ratio) | -0.73 |
| Sharpe Ratio 12m | -0.72 |
| Alpha | -182.33 |
| Beta | 17.400 |
| Volatility | 247.66% |
| Current Volume | 217923.7k |
| Average Volume 20d | 113902.7k |
| Stop Loss | 1.3 (-10.3%) |
| Signal | 0.09 |
Piotroski VR‑10 (Strict, 0-10) 0.5
| Net Income (-7.57m TTM) > 0 and > 6% of Revenue (6% = 45.6k TTM) |
| FCFTA -1.85 (>2.0%) and ΔFCFTA -1.00pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 285.1% (prev 491.2%; Δ -206.1pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -1.79 (>3.0%) and CFO -5.84m > Net Income -7.57m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 4.74 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (15.6m) change vs 12m ago 426.7% (target <= -2.0% for YES) |
| Gross Margin -988.1% (prev 50.02%; Δ -1038 pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 26.62% (prev 14.67%; Δ 11.95pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -3283 (EBITDA TTM -7.57m / Interest Expense TTM 2306 ) >= 6 (WARN >= 3) |
Altman Z'' -59.43
| (A) 0.66 = (Total Current Assets 2.74m - Total Current Liabilities 578.4k) / Total Assets 3.26m |
| (B) -5.01 = Retained Earnings (Balance) -16.3m / Total Assets 3.26m |
| warn (B) unusual magnitude: -5.01 — check mapping/units |
| (C) -2.65 = EBIT TTM -7.57m / Avg Total Assets 2.85m |
| (D) -28.23 = Book Value of Equity -16.3m / Total Liabilities 578.4k |
| Total Rating: -59.43 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 49.96
| 1. Piotroski 0.50pt = -4.50 |
| 2. FCF Yield -0.60% = -0.30 |
| 3. FCF Margin data missing |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 0.33 = 2.42 |
| 7. RoE -247.0% = -2.50 |
| 8. Rev. Trend 85.29% = 6.40 |
| 9. EPS Trend -30.98% = -1.55 |
What is the price of ASST shares?
Over the past week, the price has changed by +19.83%, over one month by -42.69%, over three months by -58.57% and over the past year by +82.21%.
Is Asset Entities Common Stock a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ASST is around 1.20 USD . This means that ASST is currently overvalued and has a potential downside of -17.24%.
Is ASST a buy, sell or hold?
What are the forecasts/targets for the ASST price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 1.4 | -1.4% |
ASST Fundamental Data Overview November 05, 2025
P/S = 202.63
P/B = 52.5862
Beta = 17.4
Revenue TTM = 759.7k USD
EBIT TTM = -7.57m USD
EBITDA TTM = -7.57m USD
Long Term Debt = 4.29m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = -2.52m USD (from netDebt column, last quarter)
Enterprise Value = 1.00b USD (1.00b + (null Debt) - CCE 2.52m)
Interest Coverage Ratio = -3283 (Ebit TTM -7.57m / Interest Expense TTM 2306 )
FCF Yield = -0.60% (FCF TTM -6.02m / Enterprise Value 1.00b)
FCF Margin = -793.0% (FCF TTM -6.02m / Revenue TTM 759.7k)
Net Margin = -996.4% (Net Income TTM -7.57m / Revenue TTM 759.7k)
Gross Margin = -988.1% ((Revenue TTM 759.7k - Cost of Revenue TTM 8.27m) / Revenue TTM)
Gross Margin QoQ = -1554 % (prev -970.5%)
Tobins Q-Ratio = 306.9 (set to none) (Enterprise Value 1.00b / Total Assets 3.26m)
Interest Expense / Debt = unknown (Interest Expense 1142 / Debt none)
Taxrate = -0.85% (negative due to tax credits) (54.1k / -6.39m)
NOPAT = -7.63m (EBIT -7.57m * (1 - -0.85%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 4.74 (Total Current Assets 2.74m / Total Current Liabilities 578.4k)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = 0.33 (negative EBITDA) (Net Debt -2.52m / EBITDA -7.57m)
Debt / FCF = 0.42 (negative FCF - burning cash) (Net Debt -2.52m / FCF TTM -6.02m)
Total Stockholder Equity = 3.06m (last 4 quarters mean from totalStockholderEquity)
RoA = -232.0% (out of range, set to none)
RoE = -247.0% (Net Income TTM -7.57m / Total Stockholder Equity 3.06m)
RoCE = -102.9% (out of range, set to none) (EBIT -7.57m / Capital Employed (Equity 3.06m + L.T.Debt 4.29m))
RoIC = -249.1% (out of range, set to none) (NOPAT -7.63m / Invested Capital 3.06m)
WACC = 70.13% (E(1.00b)/V(1.00b) * Re(70.13%) + (debt-free company))
Discount Rate = 70.13% (= CAPM, Blume Beta Adj.) -> capped to 17.95%
Shares Correlation 3-Years: 100.0 | Cagr: 134.5%
Fair Price DCF = unknown (Cash Flow -6.02m)
EPS Correlation: -30.98 | EPS CAGR: -10.99% | SUE: N/A | # QB: 0
Revenue Correlation: 85.29 | Revenue CAGR: 31.60% | SUE: N/A | # QB: 0
Additional Sources for ASST Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle